ChileChile is Latin America's most stable and transparent life-sciences market, anchored by a rigorous ISP regulatory framework and a growing private healthcare sector. Taevas provides end-to-end market entry support so your brand reaches Chilean patients and
Select an industry to see regulatory pathways, services, and how Taevas supports your Chile market entry.
Instituto de Salud Publica de Chile (ISP)
Chile's medical device market is valued at over $500 million and is regulated by the Instituto de Salud Publica de Chile (ISP), which classifies devices into four risk classes aligned with GHTF principles. Foreign manufacturers must appoint a local legal representative and obtain an ISP sanitary registration before any product can be commercialized. Taevas manages the full registration lifecycle, from technical dossier preparation to post-market surveillance, ensuring your devices reach Chilean hospitals and clinics without delay.
All medical devices sold in Chile require an ISP Registro Sanitario. The process involves submitting technical documentation, clinical evidence, and proof of market authorization in the country of origin.
ISP classifies devices into Class I through Class IV based on intended use and risk level, following GHTF guidelines. Higher-risk classes require more extensive clinical and technical documentation.
Each shipment of registered medical devices into Chile requires a valid import authorization issued by ISP. Taevas coordinates all import documentation to prevent customs delays.
ISP mandates ongoing pharmacovigilance and adverse event reporting for all registered devices. Taevas provides continuous monitoring and regulatory reporting to maintain your registration in good standing.
Taevas combines deep ISP regulatory expertise with an established network of Chilean distributors, KOLs, and healthcare institutions, giving international life-sciences brands a reliable, experienced partner from registration through revenue.
Our Santiago-based regulatory team has hands-on experience navigating ISP submissions for medical devices, pharmaceuticals, cosmetics, and food supplements, ensuring accurate dossiers and faster approvals.
Taevas covers all 15 regions of Chile, with distribution and sales infrastructure extending from Santiago's metropolitan hospitals to regional health centers in Antofagasta, Valparaiso, and Patagonia.
Our pre-built relationships with ISP reviewers, customs brokers, and established distributors compress typical Chile market entry timelines by months, giving your brand a competitive first-mover advantage.
Taevas has vetted and active relationships with Chile's leading medical, pharmaceutical, and consumer health distributors, enabling rapid channel activation without the risk of untested partnerships.
We maintain active engagement with Chile's leading physicians, pharmacists, nutritionists, and hospital procurement committees, giving your brand immediate access to the clinical voices that drive adoption.
With successful market entries across Chile, Colombia, Mexico, and Brazil, Taevas brings a proven methodology and regional intelligence that reduces risk and maximizes return on your Latin America investment.
Talk to our Chile specialists today and get a clear picture of your regulatory pathway, timeline, and commercial opportunity — at no cost and no obligation.